Trending...
- Continuous You Foundation Announces Partnership with Haawke Neural Technology
- Tacoma: Applicants Sought for the Board of Ethics
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
AI.Reverie honored for achievements advancing computer vision with synthetic data
NEW YORK - Washingtoner -- CB Insights today named AI.Reverie, the leading synthetic data platform, to its annual AI 100 ranking of the most promising private artificial intelligence companies in the world for the second time.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on Washingtoner
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
About CB Insights
More on Washingtoner
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on Washingtoner
- Haven Treatment Center Now In-Network with First Choice, Expanding Access to Youth Health
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- City of Spokane Launches 'Emergency Streets' Pilot Program
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
- An expansion of offerings into the Retail and Agriculture markets
- Inclusion in the United States Air Force's $3.3B, five-year Advance Battle Management System (ABMS) program
- A $1.5M AFWERX Phase 2 SBIR contract
- A $5.6M round of equity financing led by Vulcan
- The release of the largest open dataset of real and synthetic overhead imagery (Rareplanes, with the In-Q-Tel lab CosmiQ Works)
- Gartner recognition as a "Cool Vendor" in AI Core Technologies
- Forbes recognition as a "Top 25 Machine Learning Start-up," among other honors
About CB Insights
More on Washingtoner
- Spokane: City Seeks Feedback on Future Land Use Map
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- Longevity Academy Announces J.P. Medved of Longevity Advice as Next Guest in the Longevity Leaders
- Medcurity Introduces a Better Way for Healthcare and Its Vendors to Build Trust
- Haven Treatment Center Now In-Network Partnership with Aetna, Expanding Access to Youth Health Care
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
Source: AI.Reverie
Filed Under: Technology, Artificial Intelligence
0 Comments
Latest on Washingtoner
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Tidy-Up Tacoma Teams Up with Community Partners for Citywide Cleanup Event September 19
- Lynnwood Heating LLC Helps Homeowners Take Advantage of 2026 Heat Pump Installation Rebates
- Tacoma: Applicants Sought for the Board of Ethics
- Tacoma: Applicants Sought for the Landmarks Preservation Commission
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Tacoma: Arrest Made in 2021 Homicide
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Continuous You Foundation Announces Partnership with Haawke Neural Technology
- Metamora Events Brings New Interactive Event Experiences to Portland and Vancouver
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Lake Norman Philharmonic - Free Community Concert
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
